Craig Roberto, DO
Sports Medicine · Lockport, NYNPI 1760655203
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (41.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Prodigy Surgical Distribution, Inc. accounts for 69.7% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2022 at $10,120 and has fallen 85.6% since, to $1,455 in 2025.
Across 254 payments — averaging $130.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Prodigy Surgical Distribution, Inc.$23K
- Arthrex$7K
- Pacira Therapeutics, Inc.$859
- Stryker$746
- Ferring Pharmaceuticals Inc.$329
- Smith+Nephew$227
- plus $750 from 16 others
What the payments were for
- Travel & lodging$13,86542%
- Food & beverage$5,48917%
- Education$13,89642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Prodigy Surgical Distribution, Inc. | 45 | $23,173 |
| Arthrex | 80 | $7,166 |
| Pacira Therapeutics, Inc. | 52 | $859 |
| Stryker | 15 | $746 |
| Ferring Pharmaceuticals Inc. | 19 | $329 |
| Smith+Nephew | 6 | $227 |
| Amgen | 11 | $164 |
| Bioventus LLC | 4 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $92 |
| Pacira Pharmaceuticals Incorporated | 3 | $56 |
| Fidia Pharma USA Inc. | 2 | $49 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Nevro Corp. | 1 | $31 |
| Avanos Medical | 1 | $30 |
| Medtronic | 1 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $27 |
| Convatec Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| Ardelyx, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,251 in reported general payments places this provider in the 85th percentile of 403 sports medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 19 | $161 |
| Methylprednisolone | 20 | $141 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $100 |
| Meloxicam | 25 | $68 |
| Prednisone | 21 | $36 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Lockport
- Steven LeeNyc$3.3M
- James PaciWoodbury$2.1M
- Gregory DifeliceNew York$1.8M
- Ilya VoloshinRochester$786K
- Theodore BlaineNew York$765K
- Robert MeislinNew York$720K
- Danyal NawabiNew York$592K
- Stephen NicholasNyc$586K
- Riley WilliamsNew York$512K
- Bryan KellyNew York$409K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.